Alessandro Lupi

Showing 1-3 of 3 articles

Coronary interventions

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon

Secco G, Ghione M, Mattesini A, Dall’Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino P, Lupi A, Foin N, Di Mario C

June 20, 2016 | 10.4244/EIJY15M06_04

Coronary interventions

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions

Lupi A, Rognoni A, Lazzero M, Rolla R, Pergolini P, Bellomo G, Rossi L, Bongo A, Jaffe A

March 18, 2016 | 10.4244/EIJY14M11_04

Regarding “Clinical performance of drug-eluting stents with biodegradable polymeric coating: a meta-analysis and systematic review”

Rognoni A, Santagostino M, Sansa M, Bongo A, Lupi A

September 28, 2012 | 10.4244/EIJV8I5A99

1

Latest news

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Don’t Miss #EIJOnAir 2nd Edition!

Elective cardiac invasive procedures during the COVID-19 outbreak

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

Valvular disease